SCHEDULE: Vanguard Reports 4.99% Stake in Axogen Inc.

Vanguard Capital Management has disclosed a beneficial ownership of 4.99% in Axogen Inc., holding 2,654,445 shares as of June 30, 2026.

Summary

• Vanguard Capital Management, through its affiliates and managed accounts, now beneficially owns 2,654,445 shares of Axogen Inc. common stock.
• This represents 4.99% of the class of securities.
• The filing is an amendment (No. 1) to a Schedule 13G, indicating a change in beneficial ownership or a periodic update.
• Vanguard has sole voting power over 396,497 shares and sole dispositive power over 2,654,445 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It reports a significant ownership stake by a major institutional investor, which is generally positive, but provides no operational or financial updates on the company itself.

Positives

• Vanguard's increased stake, if interpreted as a vote of confidence, could be seen positively by the market.
• The filing confirms Vanguard's significant investment in Axogen, potentially attracting further institutional interest.

Negatives

• The filing does not contain any negative financial or operational information about Axogen; it solely reports Vanguard's ownership.

Risks

• The filing does not explicitly mention any risks related to Axogen's business operations or financial performance.

Future Outlook

The filing does not contain any forward-looking statements or guidance from Axogen Inc. It solely reports on Vanguard's ownership stake.

Management Comments

• Vanguard Capital Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.
• No one other person's interest in the securities reported herein is more than 5%.

Industry Context

StockSavvy.ai notes that significant institutional ownership, as reported by Vanguard, often signals a level of stability and potential for future growth, though it does not guarantee performance. This filing places Axogen within the typical reporting framework for companies with substantial institutional investor interest.

Stakeholder Impact

• Shareholders: The filing may increase investor confidence due to Vanguard's substantial stake, potentially influencing share price.
• Management: The increased institutional ownership may lead to closer scrutiny or engagement from Vanguard.
• Creditors: No direct impact is indicated, as the filing pertains to equity ownership.

Next Steps

• Vanguard will continue to hold and manage its investment in Axogen Inc. according to its investment strategies.
• Axogen Inc. will continue its business operations and financial reporting as usual.

Key Dates

Keywords

Axogen Inc., Vanguard Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, Securities Ownership